|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-1-4
|
|
pubmed:abstractText |
RADPLAT (concurrent selective supradose intraarterial cisplatin and external-beam irradiation) delivers extraordinarily high cisplatin concentration to head and neck structures. This study was designed to quantify and compare RADPLAT and systemic chemoradiation treatment effects on swallowing and speech.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1043-3074
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 John Wiley & Sons, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
68-77
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11774405-Adult,
pubmed-meshheading:11774405-Aged,
pubmed-meshheading:11774405-Carcinoma, Squamous Cell,
pubmed-meshheading:11774405-Cisplatin,
pubmed-meshheading:11774405-Combined Modality Therapy,
pubmed-meshheading:11774405-Deglutition Disorders,
pubmed-meshheading:11774405-Follow-Up Studies,
pubmed-meshheading:11774405-Head and Neck Neoplasms,
pubmed-meshheading:11774405-Humans,
pubmed-meshheading:11774405-Incidence,
pubmed-meshheading:11774405-Infusions, Intra-Arterial,
pubmed-meshheading:11774405-Infusions, Intravenous,
pubmed-meshheading:11774405-Middle Aged,
pubmed-meshheading:11774405-Probability,
pubmed-meshheading:11774405-Radiotherapy,
pubmed-meshheading:11774405-Risk Factors,
pubmed-meshheading:11774405-Speech Disorders
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation.
|
|
pubmed:affiliation |
University of Tennessee College of Medicine, Memphis, Tennessee, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
